NCT05888038 Virtual Reality's Effect on Decreasing Pain and Subsequent Opioid Use in Pediatric Patients in the Post-Operative Period Following Scoliosis Repair
| NCT ID | NCT05888038 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwell Health |
| Condition | Scoliosis; Juvenile |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2022-09-03 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2022-09-03 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to determine whether introducing VR in the immediate post-operative period following scoliosis repair can reduce perceived pain and stress in pediatric patients and in turn ultimately decrease opioid use. Based on previous studies that have been performed in other fields of pediatrics showing a decrease in pain and stress with VR use, the investigators hypothesize that VR will significantly decrease patient's reported level of pain and stress immediately following the VR session, and that patients will require less opioids during their inpatient stay as a result.
Eligibility Criteria
Inclusion Criteria: * all pediatric patients post scoliosis repair * age 7-21 Exclusion Criteria: * age less than 7 years; * history of seizures, epilepsy, * history of motion sickness/balance problems, * susceptibility to migraines * currently pregnant
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05888038 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 21 Years, studying Scoliosis; Juvenile. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05888038 currently recruiting?
Yes, NCT05888038 is actively recruiting participants. Contact the research team at eromanos@northwell.edu for enrollment information.
Where is the NCT05888038 trial being conducted?
This trial is being conducted at Staten Island, United States.
Who is sponsoring the NCT05888038 clinical trial?
NCT05888038 is sponsored by Northwell Health. The trial plans to enroll 50 participants.